Related Experiment Videos
Safety of oral vancomycin in functionally anephric patients
Antimicrobial Agents and Chemotherapy
|October 1, 1978
Abstract:
Administration of a vancomycin oral solution, 2 g daily for 16 days, to functionally anephric patients without inflammatory bowel disease resulted in assayable but low (
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Duplicated pituitary gland and odontoid process. A case report.
The neuroradiology journal·2013
Troublesome lipomata of the upper extremity.
The Journal of bone and joint surgery. American volume·2009
Primary signet ring cell carcinoma of the eyelid: report of a case demonstrating further analogy to lobular carcinoma of the breast with a literature review.
The American Journal of dermatopathology·2002
The autogenous dermis-fat orbital implant in children.
Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2001
Antifungal activity of the nucleoside mimetic 5-fluorouridine against Candidozyma auris and Candida species.
Antimicrobial agents and chemotherapy·2026
Antibacterial and antivirulence activities of abafungin against Clostridioides difficile: in vitro and in vivo studies.
Antimicrobial agents and chemotherapy·2026
Emergence and local dissemination of NDM-14-producing Klebsiella pneumoniae ST147: a phylodynamic and epidemiological investigation.
Antimicrobial agents and chemotherapy·2026
The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis.
Antimicrobial agents and chemotherapy·2026
NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition.
Antimicrobial agents and chemotherapy·2026
Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China.
Antimicrobial agents and chemotherapy·2026
Banff Liver Allograft Pathology Group: late rejection activity is insufficiently represented in the current diagnostic framework - rationale and goals for revision.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026